PF-00345439

· Pain Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-00345439, covering 2016-04-04 to 2016-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions [Phase 1]